Old Web
English
Sign In
Acemap
>
authorDetail
>
Raymond Fong
Raymond Fong
Manhattan Eye, Ear and Throat Hospital
Ophthalmology
Cataract surgery
Medicine
Diabetes mellitus
Adverse effect
5
Papers
61
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies
2019
Clinical Ophthalmology
Raymond Fong
Megan E. Cavet
Heleen H DeCory
Jason L. Vittitow
Show All
Source
Cite
Save
Citations (3)
Proportion of subjects achieving zero-trace anterior chamber inflammation with loteprednol etabonate (submicron) gel 0.38% following cataract surgery: Integrated analysis of 3 pivotal trials
2019
Investigative Ophthalmology & Visual Science
Joseph R. Martel
Raymond Fong
Megan E. Cavet
Jason L. Vittitow
Show All
Source
Cite
Save
Citations (0)
Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: Phase 3 study
2014
Journal of Cataract and Refractive Surgery
Satish S. Modi
Robert Lehmann
Thomas R Walters
Raymond Fong
William Christie
Lawrence Roel
David Nethery
Dana Sager
Alexis Tsorbatzoglou
Bo Philipson
Carlo Enrico Traverso
Harvey Reiser
Show All
Source
Cite
Save
Citations (26)
Once daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and pain
2011
Current Medical Research and Opinion
Steven Silverstein
Melissa G. Cable
Ehsan Sadri
James H. Peace
Raymond Fong
Simon P. Chandler
James A. Gow
Sharon M. Klier
Timothy R. McNamara
Show All
Source
Cite
Save
Citations (26)
1